LATEST NEWS
Extended-Release Subcutaneous Bupivacaine May Provide Analgesia Up to 96 Hours
Tecovirimat Shown to Alleviate Severe Proctitis in Patients With Monkeypox
Chronic Kidney Disease Risk Increased for Metabolically Healthy Individuals With Obesity
Substance Use Disorder Treatment Admissions Decreased During Pandemic
Nutrition Labels to Move to Front of Packaging Under Biden Plan
Odds of Fair, Poor Health Increased for Low-Income Cancer Survivors
Anticentromere Antibodies Can Serve as Diagnostic Marker for Sjögren Syndrome
Pfizer, BioNTech Seek to Extend Authorization for Omicron-Adapted Booster to Children
High Rate of Undiagnosed axSpA Among Patients With Inflammatory Bowel Disease
Potential Risk Factors Identified in “Long COVID”
Virtual Reality May Reduce Anesthesia Needs During Hand Surgery
LATEST FEATURES
Focus on Cardiometabolic Disease Risk in Psoriatic Arthritis – With Brittany Weber, MD
Brittany Weber, MD, who specializes in cardio-rheumatology, discusses the risks, incidence, and prevalence of cardiometabolic disease in psoriatic arthritis, and how providers must create awareness among patients.
Caution Urged About Ageism in Patient Care
Clinicians need to be aware of their assumptions about patients based on age.
Provider Implicit Bias: Bringing Awareness to Clinical Practice
Implicit bias among health care providers factors into judgments and influences clinical decision making.
Link Between Gout and Cardiovascular Events – An Interview With Robert Keenan, MD
Based on recent study findings, Robert Keenan, MD, discusses the risk for cardiovascular events among patients with gout.
OPINIONS
All the Guidelines in the World Can’t Eliminate Gray Areas
Jim Anderson, MPAS, PA-C, explores the role and limits of guidelines. He notes: Whether these practice aids are considered friends or foes, they can never eliminate the inevitable gray areas.
Defining “Disease Modification” in SLE: A Step Toward Improving Outcomes
An immunologist proposes a standard definition for “disease modification” in systemic lupus erythematosus to establish treatment targets in clinical trials and clinical practice.
Why Connections Between Immune-Mediated Diseases and Therapeutic Areas Matter
Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
Changing the Standard of Care: The Case for Combining Pegloticase With Immunomodulatory Agents in Gout
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
COVID-19 Fatigue: Is It Over Yet?
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
PODCASTS
Legal Considerations for Telemedicine Practice in a Post-Pandemic World
Gout Among Women: Not Just a “Man’s Disease”
It’s Time We Took Chronic Pain in Rheumatology Seriously
The Elephant in the Rheum – “Burnout” Among the Workforce
In Rare We Care: Pediatric Rheumatic Disease Awareness & Management
CASE STUDIES
Case Study: ANCA-negative Small Vessel Vasculitis
Case study of a 70-year-old man who presents with vague signs of a rheumatic disease.
Case Study: COVID-19 and Cardiogenic Shock
The authors describe how to diagnose and treat comorbid cardiogenic shock and COVID-19 in this case study.
Case Study: Rheumatic Disease Presents With Rare Cardiac Manifestation
Case study of a woman with a rare cardiac manifestation of a rheumatic disease.
Case Study: Inflammatory Disease Presenting as a Doughnut Sign
Case study of a 37-year-old woman with a unique presentation of an inflammatory disease.
Case Study: Systemic Lupus Erythematosus With Lupus Nephritis and Thrombotic Microangiopathy
A 19-year-old woman presents with complaints of progressive shortness of breath, chest pain, and lower extremity edema over the past month.
- Loading...
Loading...
Loading... 
Loading...